Sort by
Refine Your Search
-
St. Jude is seeking outstanding candidates for postdoctoral fellowship positions in the Childhood Hematological Malignancies Training Program. This prestigious, NIH-sponsored T32 training program
-
We are seeking a highly motivated and creative candidate for a fully supported postdoctoral fellowship to develop immune-based therapies. Specifically, the research is aimed to develop cell-based immunotherapies for pediatric tumors. Studies are focused on using genetic engineering approaches to...
-
redox balance. Our studies explore how p53 integrates metabolic cues by acting as both a sensor and regulator of cellular metabolism. In parallel, we are identifying metabolic changes that promote tumor
-
to prevent the onset of cancer. In parallel, our research is dedicated to advancing our understanding of bladder tumor evolution biology through the analysis of next-generation sequencing (NGS) data and the
-
to understand cancer development and to develop new therapeutic strategies. The Fred Hutch/University of Washington Head and Neck Research Program- Fred Hutch and the University of Washington have a world-class
-
have a unique gene expression program and atypical chromosome segregation during mitosis; yet, the underlying mechanisms remain elusive. The goals are to elucidate the chromatin structure and associated
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
-malignant blood diseases, such as sickle cell disease, bone marrow failure syndromes, and myeloproliferative disorders. This premier NHLBI-sponsored T32 training program leverages the exceptional research
-
Postdoctoral Research Associate- Training in the Design & Development of Infectious Disease Therapeu
St. Jude is seeking outstanding candidates for postdoctoral fellowship positions in infectious disease therapeutics. This NIH sponsored training program has been designed to leverage the outstanding
-
. The Medical University of Vienna provides an excellent research environment including state-ofthe-art research core facilities and an international PhD program and various platforms which bring together
-
. At the heart of our program is the GLICO (Glioma-in-a-Cerebral-Organoid)platform, a system we pioneered where patient-derived glioma stem cells are grown within human cerebral organoids. This high-fidelity model